150 related articles for article (PubMed ID: 32028646)
1. 5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease.
Banaszczak M; Maciejewska D; Drozd A; Ryterska K; Milc DJ; Raszeja-Wyszomirska J; Wunsch E; González-Muniesa P; Stachowska E
Medicina (Kaunas); 2020 Feb; 56(2):. PubMed ID: 32028646
[No Abstract] [Full Text] [Related]
2. Metabolites of arachidonic acid and linoleic acid in early stages of non-alcoholic fatty liver disease--A pilot study.
Maciejewska D; Ossowski P; Drozd A; Ryterska K; Jamioł-Milc D; Banaszczak M; Kaczorowska M; Sabinicz A; Raszeja-Wyszomirska J; Stachowska E
Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt B):184-9. PubMed ID: 26408952
[TBL] [Abstract][Full Text] [Related]
3. Eicosanoids in Nonalcoholic Fatty Liver Disease (NAFLD) Progression. Do Serum Eicosanoids Profile Correspond with Liver Eicosanoids Content during NAFLD Development and Progression?
Maciejewska D; Drozd A; Skonieczna-Żydecka K; Skórka-Majewicz M; Dec K; Jakubczyk K; Pilutin A; Stachowska E
Molecules; 2020 Apr; 25(9):. PubMed ID: 32349225
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid changes help to better understand regression of nonalcoholic fatty liver disease.
Maciejewska D; Drozd A; Ossowski P; Ryterska K; Jamioł-Milc D; Banaszczak M; Raszeja-Wyszomirska J; Kaczorowska M; Sabinicz A; Stachowska E
World J Gastroenterol; 2015 Jan; 21(1):301-10. PubMed ID: 25574105
[TBL] [Abstract][Full Text] [Related]
5. Obesity is positively associated with arachidonic acid-derived 5- and 11-hydroxyeicosatetraenoic acid (HETE).
Pickens CA; Sordillo LM; Zhang C; Fenton JI
Metabolism; 2017 May; 70():177-191. PubMed ID: 28403941
[TBL] [Abstract][Full Text] [Related]
6. The Relationship between Eicosanoid Levels and Serum Levels of Metabolic and Hormonal Parameters Depending on the Presence of Metabolic Syndrome in Patients with Benign Prostatic Hyperplasia.
Grzesiak K; Rył A; Stachowska E; Słojewski M; Rotter I; Ratajczak W; Sipak O; Piasecka M; Dołęgowska B; Laszczyńska M
Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30897712
[No Abstract] [Full Text] [Related]
7. Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease.
Ristic-Medic D; Kovacic M; Takic M; Arsic A; Petrovic S; Paunovic M; Jovicic M; Vucic V
Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374554
[TBL] [Abstract][Full Text] [Related]
8. Gut Permeability Might be Improved by Dietary Fiber in Individuals with Nonalcoholic Fatty Liver Disease (NAFLD) Undergoing Weight Reduction.
Krawczyk M; Maciejewska D; Ryterska K; Czerwińka-Rogowska M; Jamioł-Milc D; Skonieczna-Żydecka K; Milkiewicz P; Raszeja-Wyszomirska J; Stachowska E
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453660
[TBL] [Abstract][Full Text] [Related]
9. [Isomeric specific analysis of hydroxyeicosatetraenoic acid in blood samples from obese patients with non-alcoholic and alcoholic steatohepatitis].
Selezneva KS; Isakov VA; Éller KI; Goriainov SV; Kirillova OO; Sentsova TB
Vopr Pitan; 2014; 83(5):12-9. PubMed ID: 25816621
[TBL] [Abstract][Full Text] [Related]
10. Changes of the Fatty Acid Profile in Erythrocyte Membranes of Patients following 6-Month Dietary Intervention Aimed at the Regression of Nonalcoholic Fatty Liver Disease (NAFLD).
Maciejewska D; Marlicz W; Ryterska K; Banaszczak M; Jamioł-Milc D; Stachowska E
Can J Gastroenterol Hepatol; 2018; 2018():5856201. PubMed ID: 30631760
[TBL] [Abstract][Full Text] [Related]
11. Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Feldstein AE; Lopez R; Tamimi TA; Yerian L; Chung YM; Berk M; Zhang R; McIntyre TM; Hazen SL
J Lipid Res; 2010 Oct; 51(10):3046-54. PubMed ID: 20631297
[TBL] [Abstract][Full Text] [Related]
12. Effect of a high monounsaturated vs high polyunsaturated fat hypocaloric diets in nonalcoholic fatty liver disease.
Aller R; de Luis DA; Izaola O; de la Fuente B; Bachiller R
Eur Rev Med Pharmacol Sci; 2014; 18(7):1041-7. PubMed ID: 24763885
[TBL] [Abstract][Full Text] [Related]
13. Improvement of nonalcoholic fatty liver disease in morbidly obese patients after sleeve gastrectomy: association of ultrasonographic findings with lipid profile and liver enzymes.
Ruiz-Tovar J; Alsina ME; Alpera MR;
Acta Chir Belg; 2017 Dec; 117(6):363-369. PubMed ID: 28585487
[TBL] [Abstract][Full Text] [Related]
14. Hypoadiponectinaemia in nonalcoholic fatty liver disease obese women is associated with infrequent intake of dietary sucrose and fatty foods.
Magalhães GC; Feitoza FM; Moreira SB; Carmo AV; Souto FJ; Reis SR; Martins MS; Gomes da Silva MH
J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():301-12. PubMed ID: 23790128
[TBL] [Abstract][Full Text] [Related]
15. Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial.
Cai H; Qin YL; Shi ZY; Chen JH; Zeng MJ; Zhou W; Chen RQ; Chen ZY
BMC Gastroenterol; 2019 Dec; 19(1):219. PubMed ID: 31852444
[TBL] [Abstract][Full Text] [Related]
16. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
[TBL] [Abstract][Full Text] [Related]
17. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.
Suh JB; Kim SM; Cho GJ; Choi KM
Scand J Gastroenterol; 2014 Aug; 49(8):979-85. PubMed ID: 24957697
[TBL] [Abstract][Full Text] [Related]
18. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
[TBL] [Abstract][Full Text] [Related]
19. The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial.
Razavi Zade M; Telkabadi MH; Bahmani F; Salehi B; Farshbaf S; Asemi Z
Liver Int; 2016 Apr; 36(4):563-71. PubMed ID: 26503843
[TBL] [Abstract][Full Text] [Related]
20. Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease.
Abenavoli L; Greco M; Nazionale I; Peta V; Milic N; Accattato F; Foti D; Gulletta E; Luzza F
Expert Rev Gastroenterol Hepatol; 2015 Apr; 9(4):519-27. PubMed ID: 25617046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
